DOCSLIB.ORG

Understanding Hormone Highs & Lows

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Understanding Hormone Highs & Lows UNDERSTANDING HORMONE HIGHS & LOWS ESTROGENS “Estradiol, even Estradiol (E2) is the most potent of the three natural estrogens, at normal, which include estrone (E1) and estriol (E3). Estrogens play important roles in stimulating growth of the reproductive tissues, maintaining premenopausal healthy bones, increasing the levels of neurotransmitters in the levels, can brain, and helping keep the cardiovascular system healthy. cause estrogen LOW ESTRADIOL in premenopausal women is unusual unless they experience dominance an anovulatory cycle (no ovulation) or are supplementing with birth control pills, symptoms if which can suppress endogenous (made in the body) production of estrogens not balanced by the ovaries. A low estradiol level is much more common in postmenopausal women or in women of any age who have had their ovaries surgically removed by adequate (oophorectomy) and/or those who have not been treated with hormone progesterone.” replacement. Symptoms and conditions commonly associated with estrogen deficiency include hot flashes, night sweats, sleep disturbances, foggy thinking, vaginal dryness, incontinence, thinning skin, bone loss, and heart palpitations. HIGH ESTRADIOL in premenopausal women is usually caused by excessive production of androgens (testosterone and DHEA) by the ovaries and adrenal glands, which are converted to estrogens by the ‘aromatase’ enzyme found in adipose (fat) tissue. When estrogen levels are high in postmenopausal women, this is usually due to estrogen supplementation or slow clearance from the body (sluggish liver function). Excess estrogen levels, especially in combination with low progesterone, may lead to the symptoms of “estrogen dominance,” including: mood swings, irritability, anxiety, water retention, fibrocystic breasts, weight gain in the hips, bleeding changes (due to overgrowth of the uterine lining and uterine fibroids) and thyroid deficiency. Estradiol, even at normal, premenopausal levels, can cause estrogen dominance symptoms if not balanced by adequate progesterone. Diet, exercise, nutritional supplements, cruciferous vegetable extracts, herbs and foods that are natural aromatase inhibitors 866.600.1636 | [email protected] zrtlab.com Copyright © 2020 ZRT Laboratory, LLC. All rights reserved. Revised 6.17.2020 and bioidentical progesterone (e.g., transference from someone using “Younger can help to reduce the estrogen progesterone cream), and/or sluggish women with burden and symptoms, naturally. metabolism. Transdermal (through the skin) progesterone is well absorbed regular cycles PROGESTERONE at physiological levels (10-30 mg/ generally Progesterone is manufactured in day). Progesterone results higher than make adequate the ovaries at about 10-30 mg of the reference range can occur with progesterone, progesterone each day during the topical doses greater than 30 mg. consistent latter half of the menstrual cycle (luteal Note: a significant number of individuals with their phase). Younger women with regular in this range are without adverse cycles generally make adequate symptoms, indicating that a high having fewer progesterone, consistent with their progesterone level is associated with symptoms having fewer symptoms of estrogen few side effects. Symptoms of high of estrogen excess. Progesterone is important progesterone are relatively benign excess.” in normal menstrual cycles, breast and include excessive sleepiness, development, maintaining pregnancy, dizziness, bloating, susceptibility to relaxing blood vessels and influencing yeast infections, and functional estrogen neurotransmitters in the brain. deficiency (more problematic when LOW PROGESTERONE in premenopausal estradiol levels are low/low normal). women is more commonly seen with RATIO OF PROGESTERONE/ESTRADIOL anovulatory cycles, (no ovulation), The ideal ratio of progesterone/ luteal insufficiency (ovulation with low estradiol ranges from 100-500 in progesterone production), or use of premenopausal and postmenopausal contraceptives containing synthetic women supplementing with progestins. A lower level of progesterone progesterone. The ideal ratio is is more common in postmenopausal not useful in postmenopausal women who no longer ovulate, who have women with low estrogen levels had their ovaries removed, or who use and women on synthetic hormones; synthetic progestins in HRT (Provera). e.g. oral contraceptives or conventional Synthetic progestins are not detected hormone replacement therapy (HRT). by the highly specific immunoassays used to quantify progesterone. TESTOSTERONE HIGH PROGESTERONE in normal Testosterone is an anabolic hormone premenopausal and postmenopausal produced predominately by the ovaries women can occur with excessive in women and the testes in men, and supplementation, incidental exposure to a lesser extent in the adrenal glands. It is essential for creating energy, HORMONE HIGHS & LOWS | Patient HandOut 2 maintaining optimal brain function syndrome. Symptoms include loss of “Slightly elevated (memory), regulating the immune scalp hair, increased body and facial hair, testosterone system, and building and maintaining acne, and oily skin. Supplementation with the integrity of structural tissues such as topical testosterone at doses in excess of (range 50- skin, muscles, and bone. Premenopausal levels produced by the ovaries (0.3-1 mg) 60 pg/ml) is testosterone levels usually fall within the or testes (5-10 mg) can raise testosterone often seen in high-normal range and postmenopausal to levels beyond physiological range. postmenopausal levels at low-normal range. In men women as they testosterone levels peak in the teens DHEA and then fall throughout adulthood. DHEA Is a testosterone precursor shown transition into to have direct effects on the immune menopause.” LOW TESTOSTERONE is most commonly system independent of testosterone. caused by aging, removal of the ovaries or testes, suppression of ovarian and DHEA and its sulfated form, DHEAS, testicular production by stress hormones are produced predominately by the (cortisol), use of contraceptives and adrenal glands. Youthful levels are synthetic HRT, and/or damage to the at the high end of the range; levels ovaries, testes and adrenal glands decrease with age and are usually at the by trauma, medications, or radiation lower end of normal in healthy middle- therapies. Chronically low testosterone aged individuals. Athletes tend to have can cause loss of bone and/or muscle higher than normal DHEAS levels. Low mass, erectile dysfunction, thinning DHEAS can be caused by adrenal skin, vaginal dryness, low libido, exhaustion and is commonly seen in incontinence, fatigue, aches and pains, accelerated aging and diseases such depression, and memory lapses. as cancer. High DHEAS is associated with insulin resistance/PCOS (polycystic HIGH TESTOSTERONE is usually the ovaries) or DHEA supplementation. result of excessive production by the ovaries, testes and adrenal glands CORTISOL or supplementation with androgens Cortisol is produced by the adrenal (testosterone, DHEA). Slightly elevated glands in response to stressors, both testosterone (range 50-60 pg/ml) is daily (e.g. waking up, low blood sugar) often seen in postmenopausal women and unusual (e.g. emotional upset, as they transition into menopause. High infections, injury, surgery). Cortisol testosterone in premenopausal women levels are highest in the morning, and is associated with polycystic ovarian then drop steadily throughout the day syndrome (PCOS), which in turn is to their lowest point during sleep. caused by insulin resistance/metabolic HORMONE HIGHS & LOWS | Patient HandOut 3 Cortisol is essential in regulating and supplements are often helpful in “While normal mobilizing the immune system against correcting low cortisol (hypoadrenia). levels of cortisol infections and reducing inflammation. It HIGH CORTISOL suggests some are essential for helps to mobilize glucose, the primary energy source for the brain, and form of adrenal stress (see above), life and optimal maintain normal blood sugar levels. supplementation with topical functioning of hydrocortisone or use of corticosteroid While normal levels of cortisol are other hormones, medication. Heightened cortisol essential for life and optimal functioning particularly production by the adrenal glands is of other hormones, particularly thyroid a normal response to routine stress thyroid hormone, chronically elevated levels and essential for health; when stress is hormone, can be detrimental to health. Stress chronic and cortisol output remains high and persistently elevated cortisol chronically over a prolonged period (months/years), levels can contribute to premature elevated breakdown of normal tissues (muscle aging and chronic illness. levels can be wasting, thinning of skin, bone loss) and LOW CORTISOL, particularly if low immune suppression can result. Common detrimental throughout the day indicates adrenal symptoms of chronic high cortisol include to health.” exhaustion, caused by some form sleep disturbances, fatigue, depression, of stressor, e.g. emotional stress, weight gain in the waist, anxiety. sleep deprivation, poor diet, nutrient deficiencies (particularly low vitamins For more information and recommended C and B5), physical or chemical reading please visit www.zrtlab.com. insults (chemo, radiation) or synthetic glucocorticoid medications that suppress cortisol production. Chronic stress depletes cortisol and is associated with symptoms of fatigue, allergies (immune dysfunction), chemical sensitivity, cold body temp, and sugar craving. Symptoms of thyroid deficiency can also stem from low cortisol. Adequate sleep, gentle exercise, meditation, proper diet (adequate protein), ‘bioidentical’ progesterone, adrenal extracts, herbal, and nutritional HORMONE HIGHS & LOWS | Patient HandOut 4.
Load more

Recommended publications
  • This Fact Sheet Provides Information to Patients with Eczema and Their Carers. About Topical Corticosteroids How to Apply Topic
    This fact sheet provides information to patients with eczema and their carers. About topical corticosteroids You or your child’s doctor has prescribed a topical corticosteroid for the treatment of eczema. For treating eczema, corticosteroids are usually prepared in a cream or ointment and are applied topically (directly onto the skin). Topical corticosteroids work by reducing inflammation and helping to control an over-reactive response of the immune system at the site of eczema. They also tighten blood vessels, making less blood flow to the surface of the skin. Together, these effects help to manage the symptoms of eczema. There is a range of steroids that can be used to treat eczema, each with different strengths (potencies). On the next page, the potencies of some common steroids are shown, as well as the concentration that they are usually used in cream or ointment preparations. Using a moisturiser along with a steroid cream does not reduce the effect of the steroid. There are many misconceptions about the side effects of topical corticosteroids. However these treatments are very safe and patients are encouraged to follow the treatment regimen as advised by their doctor. How to apply topical corticosteroids How often should I apply? How much should I apply? Apply 1–2 times each day to the affected area Enough cream should be used so that the of skin according to your doctor’s instructions. entire affected area is covered. The cream can then be rubbed or massaged into the Once the steroid cream has been applied, inflamed skin. moisturisers can be used straight away if needed.
    [Show full text]
  • Actions of Vasoactive Intestinal Peptide on the Rat Adrenal Zona Glomerulosa
    51 Actions of vasoactive intestinal peptide on the rat adrenal zona glomerulosa J P Hinson, J R Puddefoot and S Kapas1 Molecular and Cellular Biology Section, Division of Biomedical Sciences, St Bartholomew’s and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, Mile End Road, London E1 4NS, UK 1Oral Diseases Research Centre, St Bartholomew’s and The Royal London School of Medicine and Dentistry, 2 Newark Street, London E1 2AT, UK (Requests for offprints should be addressed to J P Hinson) Abstract Previous studies, by this group and others, have shown that The response to VIP in adrenals obtained from rats fed vasoactive intestinal peptide (VIP) stimulates aldosterone a low sodium diet was also investigated. Previous studies secretion, and that the actions of VIP on aldosterone have found that adrenals from animals on a low sodium secretion by the rat adrenal cortex are blocked by â diet exhibit increased responsiveness to VIP. Specific VIP adrenergic antagonists, suggesting that VIP may act by binding sites were identified, although the concentration the local release of catecholamines. The present studies or affinity of binding sites in the low sodium group was not were designed to test this hypothesis further, by measur- significantly different from the controls. In the low sodium ing catecholamine release by adrenal capsular tissue in group VIP was found to increase catecholamine release to response to VIP stimulation. the same extent as in the control group, however, in Using intact capsular tissue it was found that VIP caused contrast to the control group, the adrenal response to VIP a dose-dependent increase in aldosterone secretion, with a was not altered by adrenergic antagonists in the low concomitant increase in both adrenaline and noradrenaline sodium group.
    [Show full text]
  • Affect Breast Cancer Risk
    HOW HORMONES AFFECT BREAST CANCER RISK Hormones are chemicals made by the body that control how cells and organs work. Estrogen is a female hormone made mainly in the ovaries. It’s important for sexual development and other body functions. From your first monthly period until menopause, estrogen stimulates normal breast cells. A higher lifetime exposure to estrogen may increase breast cancer risk. For example, your risk increases if you start your period at a young age or go through menopause at a later age. Other hormone-related risks are described below. Menopausal hormone therapy Pills Menopausal hormone therapy (MHT) is The U.S. Food and Drug Administration also known as postmenopausal hormone (FDA) recommends women use the lowest therapy and hormone replacement dose that eases symptoms for the shortest therapy. Many women use MHT pills to time needed. relieve hot flashes and other menopausal Any woman currently taking or thinking symptoms. MHT should be used at the Birth control about taking MHT pills should talk with her lowest dose and for the shortest time pills (oral doctor about the risks and benefits. contraceptives) needed to ease menopausal symptoms. Long-term use can increase breast cancer Vaginal creams, suppositories Current or recent use risk and other serious health conditions. and rings of birth control pills There are 2 main types of MHT pills: slightly increases breast Vaginal forms of MHT do not appear to cancer risk. However, estrogen plus progestin and estrogen increase the risk of breast cancer. However, this risk is quite small alone. if you’ve been diagnosed with breast cancer, vaginal estrogen rings and suppositories are because the risk of Estrogen plus progestin MHT breast cancer for most better than vaginal estrogen creams.
    [Show full text]
  • 4. Antibacterial/Steroid Combination Therapy in Infected Eczema
    Acta Derm Venereol 2008; Suppl 216: 28–34 4. Antibacterial/steroid combination therapy in infected eczema Anthony C. CHU Infection with Staphylococcus aureus is common in all present, the use of anti-staphylococcal agents with top- forms of eczema. Production of superantigens by S. aureus ical corticosteroids has been shown to produce greater increases skin inflammation in eczema; antibacterial clinical improvement than topical corticosteroids alone treatment is thus pivotal. Poor patient compliance is a (6, 7). These findings are in keeping with the demon- major cause of treatment failure; combination prepara- stration that S. aureus can be isolated from more than tions that contain an antibacterial and a topical steroid 90% of atopic eczema skin lesions (8); in one study, it and that work quickly can improve compliance and thus was isolated from 100% of lesional skin and 79% of treatment outcome. Fusidic acid has advantages over normal skin in patients with atopic eczema (9). other available topical antibacterial agents – neomycin, We observed similar rates of infection in a prospective gentamicin, clioquinol, chlortetracycline, and the anti- audit at the Hammersmith Hospital, in which all new fungal agent miconazole. The clinical efficacy, antibac- patients referred with atopic eczema were evaluated. In terial activity and cosmetic acceptability of fusidic acid/ a 2-month period, 30 patients were referred (22 children corticosteroid combinations are similar to or better than and 8 adults). The reason given by the primary health those of comparator combinations. Fusidic acid/steroid physician for referral in 29 was failure to respond to combinations work quickly with observable improvement prescribed treatment, and one patient was referred be- within the first week.
    [Show full text]
  • A Guide to Feminizing Hormones – Estrogen
    1 | Feminizing Hormones ​ ​ A Guide to Feminizing Hormones Hormone therapy is an option that can help transgender and gender-diverse people feel more comfortable in their bodies. Like other medical treatments, there are benefits and risks. Knowing what to expect will help us work together to maximize the benefits and minimize the risks. What are hormones? Hormones are chemical messengers that tell the body’s cells how to function, ​ when to grow, when to divide, and when to die. They regulate many functions, including growth, sex drive, hunger, thirst, digestion, metabolism, fat burning & storage, blood sugar, cholesterol levels, and reproduction. What are sex hormones? Sex hormones regulate the development of sex characteristics, including the sex ​ organs such as genitals and ovaries/testicles. Sex hormones also affect the secondary sex characteristics that typically develop at puberty, like facial and body hair, bone growth, breast growth, and voice changes. There are three categories of sex hormones in the body: • Androgens: testosterone, dehydroepiandrosterone (DHEA), ​ dihydrotestosterone (DHT) • Estrogens: estradiol, estriol, estrone ​ • Progestin: progesterone ​ Generally, “males” tend to have higher androgen levels, and “females” tend to have higher levels of estrogens and progestogens. What is hormone therapy? Hormone therapy is taking medicine to change the levels of sex hormones in your body. Changing these levels will affect your hair growth, voice pitch, fat distribution, muscle mass, and other features associated with sex and gender. Feminizing hormone therapy can help make the body look and feel less “masculine” and more “feminine" — making your body more closely match your identity. What medicines are involved? There are different kinds of medicines used to change the levels of sex hormones in your body.
    [Show full text]
  • Antiestrogenic Action of Dihydrotestosterone in Mouse Breast
    Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor. R W Casey, J D Wilson J Clin Invest. 1984;74(6):2272-2278. https://doi.org/10.1172/JCI111654. Research Article Feminization in men occurs when the effective ratio of androgen to estrogen is lowered. Since sufficient estrogen is produced in normal men to induce breast enlargement in the absence of adequate amounts of circulating androgens, it has been generally assumed that androgens exert an antiestrogenic action to prevent feminization in normal men. We examined the mechanisms of this effect of androgens in the mouse breast. Administration of estradiol via silastic implants to castrated virgin CBA/J female mice results in a doubling in dry weight and DNA content of the breast. The effect of estradiol can be inhibited by implantation of 17 beta-hydroxy-5 alpha-androstan-3-one (dihydrotestosterone), whereas dihydrotestosterone alone had no effect on breast growth. Estradiol administration also enhances the level of progesterone receptor in mouse breast. Within 4 d of castration, the progesterone receptor virtually disappears and estradiol treatment causes a twofold increase above the level in intact animals. Dihydrotestosterone does not compete for binding to the progesterone receptor, but it does inhibit estrogen-mediated increases of progesterone receptor content of breast tissue cytosol from both control mice and mice with X-linked testicular feminization (tfm)/Y. Since tfm/Y mice lack a functional androgen receptor, we conclude that this antiestrogenic action of androgen is not mediated by the androgen receptor. Dihydrotestosterone competes with estradiol for binding to the cytosolic estrogen receptor of mouse breast, […] Find the latest version: https://jci.me/111654/pdf Antiestrogenic Action of Dihydrotestosterone in Mouse Breast Competition with Estradiol for Binding to the Estrogen Receptor Richard W.
    [Show full text]
  • Salivary 17 Α-Hydroxyprogesterone Enzyme Immunoassay Kit
    SALIVARY 17 α-HYDROXYPROGESTERONE ENZYME IMMUNOASSAY KIT For Research Use Only Not for use in Diagnostic Procedures Item No. 1-2602, (Single) 96-Well Kit; 1-2602-5, (5-Pack) 480 Wells Page | 1 TABLE OF CONTENTS Intended Use ................................................................................................. 3 Introduction ................................................................................................... 3 Test Principle ................................................................................................. 4 Safety Precautions ......................................................................................... 4 General Kit Use Advice .................................................................................... 5 Storage ......................................................................................................... 5 pH Indicator .................................................................................................. 5 Specimen Collection ....................................................................................... 6 Sample Handling and Preparation ................................................................... 6 Materials Supplied with Single Kit .................................................................... 7 Materials Needed But Not Supplied .................................................................. 8 Reagent Preparation ....................................................................................... 9 Procedure ...................................................................................................
    [Show full text]
  • HORMONES and SPORT Insulin, Growth Hormone and Sport
    13 HORMONES AND SPORT Insulin, growth hormone and sport P H Sonksen Guy’s, King’s and St Thomas’ School of Medicine, St Thomas’ Hospital, London SE1 7EH, UK; Email: [email protected] Abstract This review examines some interesting ‘new’ histories of blood rather than urine samples. The first method has a insulin and reviews our current understanding of its window of opportunity lasting about 24 h after an injec- physiological actions and synergy with GH in the regu- tion and is most suitable for ‘out of competition’ testing. lation of metabolism and body composition. It reviews the The second method has reasonable sensitivity for as long as history of GH abuse that antedates by many years the 2 weeks after the last injection of GH and is uninfluenced awareness of endocrinologists to its potent anabolic actions. by extreme exercise and suitable for post-competition Promising methods for detection of GH abuse have been samples. This method has a greater sensitivity in men than developed but have yet to be sufficiently well validated to in women. The specificity of both methods seems accept- be ready for introduction into competitive sport. So far, ably high but lawyers need to decide what level of there are two promising avenues for detecting GH abuse. scientific probability is needed to obtain a conviction. Both The first uses immunoassays that can distinguish the methods need further validation before implementation. isomers of pituitary-derived GH from the monomer of Research work carried out as part of the fight against recombinant human GH. The second works through doping in sport has opened up a new and exciting area of demonstrating circulating concentrations of one or more endocrinology.
    [Show full text]
  • Feminizing Hormone Therapy
    FEMINIZING HORMONE THERAPY Julie Thompson, PA-C Medical Director of Trans Health, Fenway Health April 2020 fenwayhealth.org GOALS AND OBJECTIVES 1. Review process of initiating hormone therapy through the informed consent model 2. Provide an overview of feminizing hormone therapy 3. Review realistic expectations and benefits of hormone therapy vs their associated risks 4. Discuss recommendations for monitoring fenwayhealth.org PROTOCOLS AND STANDARDS OF CARE fenwayhealth.org WPATH STANDARDS OF CARE, 2011 The criteria for hormone therapy are as follows: 1. Well-documented, persistent (at least 6mo) gender dysphoria 2. Capacity to make a fully informed decision and to consent for treatment 3. Age of majority in a given country 4. If significant medical or mental health concerns are present, they must be reasonably well controlled fenwayhealth.org INFORMED CONSENT MODEL ▪ Requires healthcare provider to ▪ Effectively communicate benefits, risks and alternatives of treatment to patient ▪ Assess that the patient is able to understand and consent to the treatment ▪ Informed consent model does not preclude mental health care! ▪ Recognizes that prescribing decision ultimately rests with clinical judgment of provider working together with the patient ▪ Recognizes patient autonomy and empowers self-agency ▪ Decreases barriers to medically necessary care fenwayhealth.org INITIAL VISITS ▪ Review history of gender experience and patient’s goals ▪ Document prior hormone use ▪ Assess appropriateness for gender affirming medical treatment ▪ WPATH criteria
    [Show full text]
  • Structure and Origin of Uterine and Extragenital L=Ibroids Induced
    Structure and Origin of Uterine and Extragenital l=ibroids Induced Experimentally in the Guinea Pig by Prolonged Administration of Estrogens* Alexander Lipschotz, M.D., and Louis Vargas, Jr., M.D. (From Department o/ Experimental Medicine, National Health Service o/the Republic o/Chile, Santiago, Chile) (Received for publication December 13, x94o) The purpose of this communication is to present the These experimentally induced abdominal tumors findings of a detailed microscopical study of the sites present a smooth surface formed of a capsule com- of origin and stages of development of the subserous posed of flattened superficial cells (Plate 2, Figs. 2-A fibroid tumors induced in guinea pigs by prolonged and 2-B). The cells beneath the capsule resemble administration of estrogens. Details of treatment of fibroblasts. These cells have definite boundaries or the animals are given in the explanations of Plates I- 5. they are separated from each other by collagenous Subserous uterine tumors which can be induced in fibers (Plate 4, Fig. ix-C). guinea pigs by prolonged administration of estrogens, The masses of fibroid tumors arising from the apex as described by Nelson (26, 27), were found to be of the uterine horn may enclose the tubes or large fibroids. Lipschiitz, Iglesias, and Vargas (i3, 18, 22) tubal cysts. The demarcation between the muscular have shown that extragenital tumors in the abdominal coat of the tube and the tumor is not always sharp. cavity, induced by estrogens, also were fibroids. The In some instances, especially when the apical fibroid localization of these tumo~:s at various sites on the is small, the tumor is in close contact with an abun- uterus, pancreas, kidney, spleen, etc., have been de- dance of smooth muscle and adipose tissue (Plate 2, scribed by Iglesias (5), Vargas and Lipschiitz (32), Fig.
    [Show full text]
  • Degradation and Metabolite Formation of Estrogen Conjugates in an Agricultural Soil
    Journal of Pharmaceutical and Biomedical Analysis 145 (2017) 634–640 Contents lists available at ScienceDirect Journal of Pharmaceutical and Biomedical Analysis j ournal homepage: www.elsevier.com/locate/jpba Degradation and metabolite formation of estrogen conjugates in an agricultural soil a,b b,∗ Li Ma , Scott R. Yates a Department of Environmental Sciences, University of California, Riverside, CA 92521, United States b Contaminant Fate and Transport Unit, U.S. Salinity Laboratory, Agricultural Research Service, United States Department of Agriculture, Riverside, CA 92507, United States a r t i c l e i n f o a b s t r a c t Article history: Estrogen conjugates are precursors of free estrogens such as 17ß-estradiol (E2) and estrone (E1), which Received 10 April 2017 cause potent endocrine disrupting effects on aquatic organisms. In this study, microcosm laboratory Received in revised form 11 July 2017 ◦ experiments were conducted at 25 C in an agricultural soil to investigate the aerobic degradation and Accepted 31 July 2017 metabolite formation kinetics of 17ß-estradiol-3-glucuronide (E2-3G) and 17ß-estradiol-3-sulfate (E2- Available online 1 August 2017 3S). The aerobic degradation of E2-3G and E2-3S followed first-order kinetics and the degradation rates were inversely related to their initial concentrations. The degradation of E2-3G and E2-3S was extraordi- Keywords: narily rapid with half of mass lost within hours. Considerable quantities of E2-3G (7.68 ng/g) and E2-3S Aerobic degradation 17ß-estradiol-3-glucuronide (4.84 ng/g) were detected at the end of the 20-d experiment, particularly for high initial concentrations.
    [Show full text]
  • Cortisol Deficiency and Steroid Replacement Therapy
    Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Cortisol deficiency and steroid replacement therapy This leaflet explains about cortisol deficiency and how it is treated. It also contains information about how to deal with illnesses, accidents and other stressful events in children on cortisol replacement. Where are the The two most important ones are: adrenal glands and • Aldosterone – this helps regulate what do they do? the blood pressure by controlling how much salt is retained in the The adrenal glands rest on the tops body. If a person is unable to of the kidneys. They are part of the make aldosterone themselves, they endocrine system, which organises the will need to take a tablet called release of hormones within the body. ‘fludrocortisone’. Hormones are chemical messengers that switch on and off processes within the • Cortisol – this is the body’s natural body. steroid and has three main functions: The adrenal glands consist of two parts: - helping to control the blood the medulla (inner section) which sugar level makes the hormone ‘adrenaline’ which is part of the ‘fight or flight’ - helping the body deal with stress response a person has when stressed. - helping to control blood pressure the cortex (outer section) which and blood circulation. releases several hormones. If a person is unable to make cortisol themselves, they will need to take a tablet to replace it. Pituitary gland The most common form used is hydrocortisone, but other forms Parathyroid gland may be prescribed. Thyroid gland Medulla Cortex Adrenal Thymus gland Gland Kidney Adrenal gland Pancreas Sheet 1 of 7 Ref: 2014F0715 © GOSH NHS Foundation Trust March 2015 What is In these circumstances, the amount cortisol deficiency? of hydrocortisone given needs to be increased quickly.
    [Show full text]